Present and future etiological treatment of bacterial pneumonia 2. Antibiotic therapy of hospital-acquired pneumonia
Journal Title: Здоров`я дитини - Year 2017, Vol 12, Issue 4
Abstract
The choice of antibacterial drugs in the treatment of nosocomial pneumonia is a fairly complex clinical task that clearly depends on the etiology of the disease. According to the general guidelines of ATS/IDSA for antibacterial therapy, it is recommended for children with nosocomial pneumonia: to choose an antibiotic according to the sensitivity of the causative agent; to prefer the drugs with a limited range of antibacterial activity; to use a sufficient dose of antibiotic to provide an effective concentration at the site of infection. The first step in the algorithm for choosing an antibiotic may be taking into account the risk of multidrug-resistant pathogen as a causative agent of pneumonia.
Authors and Affiliations
А. Е. Abaturov, Т. А. Kryuchko
Bronchitis in Сhildren and Antitussive Therapy Selection
The paper presents an overview of the most common forms of bronchitis in children, their clinical symptoms and approaches to diagnosis. The mechanisms of cough syndrome formation and methods of its treatment are consider...
The Participation of Interleukin 1 Family in the Development of the Inflammatory Response in Infectious Process. Part 2. Role of IL-1F1 (IL-1α) and IL-1F2 (IL-1β)
The review presents the characteristics of IL-1F1 (IL-1α) and IL-1F2 (IL-1β), their receptors, mechanisms of action and value of these interleukins in the development of inflammatory response.
Optimizing the Treatment of Atopic Dermatitis in Infants Using Ursodeoxycholic Acid
Expediency of including the suspension of ursodeoxycholic acid into the combination therapy of atopic dermatitis in infants was investigated. It is proved that administration of the suspension of ursodeoxycholic acid in...
Inhibition of bacterial virulence factors as a method of treating bacterial pneumonia
Incremental increase in the number of antibiotic-resistant bacterial strains in the etiologic structure of pneumonia and reduced potential of antibiotic therapy increase the importance of drugs in the treatment of pneumo...
Drug management of oxidation-reduction state of the body in respiratory tract diseases (part 6)
The review of the literature presents modern data on antioxidant and anti-inflammatory activity of polyphenols, as well as their representatives curcumin and resveratrol in diseases of the respiratory system